ECOG-ACRIN EAY131-S2

Primary Category:

Treatment Protocols

Disease Category:

Molecular Profiling

Status:

Closed

MATCH Treatment Subprotocol S2: EAY131-S2: Phase II Study of Trametinib in Patients with Tumors with GNAQ or GNA11 mutations

(See required screening study ECOG-ACRIN EAY131)

Due to the unexpectedly low prevalence of the associated targeted aberrations in our patient population, subprotocol EAY131-S2 is closed to accrual, effective May 16th, 2019 at 5:00 pm ET.  No further treatment assignment to this subprotocol will be generated after this date, 05/16/19.

NCT#02465060